4/A//SEC Filing
Vincent Mark D. 4/A
Accession 0001567619-20-006345
CIK 0000882361other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:30 PM ET
Size
5.8 KB
Accession
0001567619-20-006345
Insider Transaction Report
Form 4/AAmended
Vincent Mark D.
Director
Transactions
- Award
Director Option Grant
2020-03-11+50,000→ 50,000 totalExercise: $7.13From: 2021-03-11Exp: 2030-03-10→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Converted from Canadian exercise price of C$9.80 using an exchange rate of 1.3745.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001761243
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 8:30 PM ET
- Size
- 5.8 KB